Scheiner B, Pinter M. Reply to: "The CRAFITY score: a promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations". J Hepatol 2022 May 5. pii: S0168-8278(22)00266.
PMID: 35526786